United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018: ResearchMoz

ResearchMoz.us include new market research report"United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" to its huge collection of research reports.United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Directs team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the United Arab Emirates In Vitro Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United Arab Emirates In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.

Table Of Contenct

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction 122.1 What is This Report About? 12

3 In Vitro Diagnostics In United Arab Emirates 133.1 In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018 13
3.2 In Vitro Diagnostics, United Arab Emirates, Company Share (2010-2011) 19

4 Clinical Chemistry In United Arab Emirates 214.1 Clinical Chemistry Overall Revenue, (2004-2018) 21
4.1.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 25
4.1.2 Urine Analysis, Revenue (2004-2018) 29
4.2 Clinical Chemistry Distribution Share (2010-2011) 33
4.3 Clinical Chemistry, United Arab Emirates, Company Share (2010-2011) 34

5 Genetic Testing In United Arab Emirates 365.1 Genetic Testing Overall Revenue, (2004-2018) 36
5.2 Genetic Testing Distribution Share (2010-2011) 40
5.3 Genetic Testing, United Arab Emirates, Company Share (2010-2011) 41

6 Haematology In United Arab Emirates 436.1 Haematology Overall Revenue, (2004-2018) 43
6.1.1 Haematology Reagents, Revenue, (2004-2018) 47
6.1.2 Immunohaematology, Revenue (2004-2018) 51
6.1.3 Haemostasis, Revenue (2004-2018) 55
6.1.4 Haematology Rapid Tests, Revenue (2004-2018) 59
6.1.5 Haematology Cell Counters, Revenue (2004-2018) 63
6.2 Haematology Distribution Share (2010-2011) 67
6.3 Haematology, United Arab Emirates, Company Share (2010-2011) 68

For More Info, Please Visit@ http://www.researchmoz.us/united-arab-emirates-in-vitro-diagnostics-investment-opportunities-analysis-and-forecasts-to-2018-report.html

7 Histology And Cytology In United Arab Emirates 707.1 Histology And Cytology Overall Revenue, (2004-2018) 70
7.2 Histology And Cytology Distribution Share (2010-2011) 74
7.3 Histology And Cytology, United Arab Emirates, Company Share (2010-2011) 75

8 Immuno Chemistry In United Arab Emirates 778.1 Immuno Chemistry Overall Revenue, (2004-2018) 77
8.1.1 Disease Specific Immunochemistry, Revenue (2004-2018) 81
8.1.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 85
8.1.3 Endocrinology Tests, Revenue (2004-2018) 88
8.1.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 92
8.1.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 96
8.1.6 Immunochemistry Analyzers, Revenue (2004-2018) 100
8.2 Immuno Chemistry Distribution Share (2010-2011) 104
8.3 Immuno Chemistry, United Arab Emirates, Company Share (2010-2011) 105

9 Infectious Immunology In United Arab Emirates 1079.1 Infectious Immunology Overall Revenue, (2004-2018) 107
9.1.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 111
9.2 Infectious Immunology Distribution Share (2010-2011) 115
9.3 Infectious Immunology, United Arab Emirates, Company Share (2010-2011) 116

10 Microbiology Culture In United Arab Emirates 11810.1 Microbiology Culture Overall Revenue, (2004-2018) 118
10.1.1 Microbiology Analyzers, Revenue (2004-2018) 122
10.2 Microbiology Culture Distribution Share (2010-2011) 126
10.3 Microbiology Culture, United Arab Emirates, Company Share (2010-2011) 127

For All Latest Market Research Reports@ http://www.researchmoz.us/report.html

11 Overview of Key Companies in United Arab Emirates In Vitro Diagnostics Market 12911.1 F. Hoffmann-La Roche Ltd. 129

11.1.1 Company Overview 129

11.2 Siemens Healthcare 129

11.2.1 Company Overview 129

11.3 Beckman Coulter, Inc. 130

11.3.1 Company Overview 130

11.4 Abbott Laboratories 130

11.4.1 Company Overview 130

11.5 Ortho-Clinical Diagnostics Inc. 131

11.5.1 Company Overview 131

11.6 bioMerieux S.A. 131

11.6.1 Company Overview 131

11.7 ELITech Group 132

11.7.1 Company Overview 132

11.8 Becton, Dickinson and Company 132

11.8.1 Company Overview 132

11.9 Alere Inc. 133

11.9.1 Company Overview 133

11.10 Mindray Medical International Limited 133

11.10.1 Company Overview 133

11.11 Bio-Rad Laboratories, Inc. 134

11.11.1 Company Overview 134

11.12 PerkinElmer, Inc. 134

11.12.1 Company Overview 134

11.13 Sysmex Corporation 135

11.13.1 Company Overview 135

11.14 Thermo Fisher Scientific Inc. 135

11.14.1 Company Overview 135

11.15 Horiba, Ltd. 136

11.15.1 Company Overview 136

11.16 Grifols, S.A. 136

11.16.1 Company Overview 136

11.17 DiaSorin S.p.A 137

11.17.1 Company Overview 137

11.18 Qiagen N.V. 137

11.18.1 Company Overview 137

11.19 Gen-Probe Incorporated 138

11.19.1 Company Overview 138

11.20 Diagnostica Stago, Inc. 138

11.20.1 Company Overview 138

11.21 Life Technologies Corporation 139

11.21.1 Company Overview 139

11.22 Hologic, Inc. 139

11.22.1 Company Overview 139

11.23 Immucor, Inc. 140

11.23.1 Company Overview 140

11.24 Chembio Diagnostics, Inc. 140

11.24.1 Company Overview 140

11.25 Phadia AB 140

11.25.1 Company Overview 140

12 Appendix 141
12.1 Global Markets Direct Research Methodology 141
12.2 Definitions of Markets Covered in the Report 142
12.2.1 In Vitro Diagnostics 142
12.3 Secondary Research 153
12.4 Primary Research 153
12.5 Models 154
12.6 Forecasts 154
12.7 Expert Panel Validation 154
12.8 Currency Conversion 155
12.9 Contact Us 155
12.10 Disclaimer 155

To know more about this reports, please visit @ http://www.researchmoz.us/united-arab-emirates-in-vitro-diagnostics-investment-opportunities-analysis-and-forecasts-to-2018-report.html

Contact: sales@researchmoz.us for further information.

Find us on: